{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:14:55Z","timestamp":1763036095259,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ejogrb.2005.11.041","type":"journal-article","created":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T09:36:36Z","timestamp":1136972196000},"page":"187-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term"],"prefix":"10.1016","volume":"128","author":[{"given":"Pieter J.","family":"van Runnard Heimel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjoke J.M.","family":"Huisjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Franx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corine","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel L.","family":"Bots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein W.","family":"Bruinse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejogrb.2005.11.041_bib1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","article-title":"Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)","volume":"169","author":"Sibai","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.11.041_bib2","series-title":"The Fifth Report of the Confidential Enquiry into Maternal Deaths in the United Kingdom","article-title":"Why mothers die 1997\u20131999","author":"Royal College of Obstetricians and Gynecologists","year":"2001"},{"issue":"6","key":"10.1016\/j.ejogrb.2005.11.041_bib3","first-page":"1070","article-title":"Aggressive or expectant management for patients with severe preeclampsia between 28\u201334 weeks\u2019 gestation: a randomized controlled trial","volume":"76","author":"Odendaal","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2005.11.041_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9378(94)90104-X","article-title":"Aggressive versus expectant management of severe preeclampsia at 28\u201332 weeks\u2019 gestation: a randomized controlled trial","volume":"171","author":"Sibai","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.11.041_bib5","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ajog.2004.03.050","article-title":"Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks\u2019 gestation","author":"Haddad","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2005.11.041_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1471-0528.1995.tb09062.x","article-title":"Temporising management of severe pre-eclampsia with and without the HELLP syndrome","volume":"102","author":"Visser","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2005.11.041_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-2115(97)00146-2","article-title":"Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome","volume":"76","author":"van Pampus","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1 Pt 1","key":"10.1016\/j.ejogrb.2005.11.041_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9378(99)70178-X","article-title":"Neonatal outcome in severe preeclampsia at 24\u201336 weeks\u2019 gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?","volume":"180","author":"Abramovici","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.11.041_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-2115(97)00146-2","article-title":"Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome","author":"van Pampus","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6 Pt 1","key":"10.1016\/j.ejogrb.2005.11.041_bib10","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/0002-9378(91)91429-Z","article-title":"The natural history of HELLP syndrome: patterns of disease progression and regression","volume":"164","author":"Martin","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2005.11.041_bib11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1067\/S0002-9378(03)00763-4","article-title":"Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome","volume":"189","author":"Martin","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2005.11.041_bib12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/01.AOG.0000143262.85124.e8","article-title":"Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome","volume":"104","author":"Rose","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2005.11.041_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002076.pub2","article-title":"Corticosteroids for HELLP syndrome in pregnancy","author":"Matchaba","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"5 Pt 1","key":"10.1016\/j.ejogrb.2005.11.041_bib14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.11.041_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/bmj.329.7460.270","article-title":"Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome","author":"Clenney","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ejogrb.2005.11.041_bib16","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0002-9378(94)90054-X","article-title":"Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)","volume":"171","author":"Magann","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2005.11.041_bib17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0022-3476(72)80547-X","article-title":"The transplacental passage of prednisone and prednisolone in pregnancy near term","volume":"81","author":"Beitins","year":"1972","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.ejogrb.2005.11.041_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0002-9378(77)90466-5","article-title":"In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta","volume":"127","author":"Blanford","year":"1977","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2005.11.041_bib19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1515\/JPM.2000.068","article-title":"Effect of corticosteroids on HELLP syndrome: a case report","volume":"28","author":"Schlembach","year":"2000","journal-title":"J Perinat Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2005.11.041_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-I","article-title":"The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?","volume":"162","author":"Sibai","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.11.041_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1471-0528.1997.tb11054.x","article-title":"Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy","author":"Girling","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2005.11.041_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00974058","article-title":"Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP)","author":"Giedion","year":"1973","journal-title":"Pediatr Radiol"},{"issue":"4","key":"10.1016\/j.ejogrb.2005.11.041_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights <1500g","volume":"92","author":"Papile","year":"1978","journal-title":"J Pediatr"},{"year":"1970","series-title":"The Abilities of Young Children: A Comprehensive System of Mental Measurement for the First 8 Years of Life","author":"Griffiths","key":"10.1016\/j.ejogrb.2005.11.041_bib24"},{"year":"1993","series-title":"Bayley Scales of Infant Development-II","author":"Bayley","key":"10.1016\/j.ejogrb.2005.11.041_bib25"},{"issue":"1","key":"10.1016\/j.ejogrb.2005.11.041_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.ogx.0000150346.42901.07","article-title":"Corticosteroids, pregnancy, and HELLP syndrome: a review","volume":"60","author":"van Runnard Heimel","year":"2005","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"10.1016\/j.ejogrb.2005.11.041_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/00365518509160999","article-title":"The stabilizing effect of glucocorticoids on human endothelial cells in culture","volume":"45","author":"Jarvelainen","year":"1985","journal-title":"Scand J Clin Lab Invest"},{"issue":"Suppl. 1","key":"10.1016\/j.ejogrb.2005.11.041_bib28","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF01844196","article-title":"An overview of glucocorticoid anti-inflammatory actions","volume":"45","author":"Schleimer","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2005.11.041_bib29","first-page":"445","article-title":"Hydrocortisone, platelet aggregation and platelet prostaglandin metabolism","author":"Jorgensen","year":"1980","journal-title":"Scand J Haematol"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505007062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505007062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:16:17Z","timestamp":1759554977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211505007062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0301211505007062"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.11.041","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}